已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

吲达帕胺 培哚普利 医学 血压 养生 内科学 利尿剂 冲程(发动机) 安慰剂 心脏病学 机械工程 工程类 病理 替代医学
作者
Stephen MacMahon
出处
期刊:The Lancet [Elsevier BV]
卷期号:358 (9287): 1033-1041 被引量:3194
标识
DOI:10.1016/s0140-6736(01)06178-5
摘要

Blood pressure is a determinant of the risk of stroke among both hypertensive and non-hypertensive individuals with cerebrovascular disease. However, there is uncertainty about the efficacy and safety of blood-pressure-lowering treatments for many such patients. The perindopril protection against recurrent stroke study (PROGRESS) was designed to determine the effects of a blood-pressure-lowering regimen in hypertensive and non-hypertensive patients with a history of stroke or transient ischaemic attack.6105 individuals from 172 centres in Asia, Australasia, and Europe were randomly assigned active treatment (n=3051) or placebo (n=3054). Active treatment comprised a flexible regimen based on the angiotensin- converting-enzyme inhibitor perindopril (4 mg daily), with the addition of the diuretic indapamide at the discretion of treating physicians. The primary outcome was total stroke (fatal or non-fatal). Analysis was by intention to treat.Over 4 years of follow up, active treatment reduced blood pressure by 9/4 mm Hg. 307 (10%) individuals assigned active treatment suffered a stroke, compared with 420 (14%) assigned placebo (relative risk reduction 28% [95% CI 17-38], p<0.0001). Active treatment also reduced the risk of total major vascular events (26% [16-34]). There were similar reductions in the risk of stroke in hypertensive and non-hypertensive subgroups (all p<0.01). Combination therapy with perindopril plus indapamide reduced blood pressure by 12/5 mm Hg and stroke risk by 43% (30-54). Single-drug therapy reduced blood pressure by 5/3 mm Hg and produced no discernable reduction in the risk of stroke.This blood-pressure-lowering regimen reduced the risk of stroke among both hypertensive and non-hypertensive individuals with a history of stroke or transient ischaemic attack. Combination therapy with perindopril and indapamide produced larger blood pressure reductions and larger risk reductions than did single drug therapy with perindopril alone. Treatment with these two agents should now be considered routinely for patients with a history of stroke or transient ischaemic attack, irrespective of their blood pressure.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
zyy发布了新的文献求助10
刚刚
tomatoGG完成签到,获得积分10
1秒前
1秒前
初一发布了新的文献求助10
1秒前
Akim的应助被易只羊采纳,获得10
2秒前
zyy发布了新的文献求助30
4秒前
追寻南珍完成签到,获得积分10
4秒前
tomatoGG发布了新的文献求助10
4秒前
4秒前
扶光hjgkk发布了新的文献求助10
5秒前
ossc发布了新的文献求助30
5秒前
SzMg完成签到,获得积分10
7秒前
武渊思完成签到,获得积分10
7秒前
CodeCraft的应助被LLL采纳,获得10
9秒前
花花完成签到 ,获得积分10
10秒前
嘻嘻哈哈的应助被zs采纳,获得10
10秒前
xinyuanjia的应助被明理的音响采纳,获得10
11秒前
张真源完成签到 ,获得积分10
11秒前
地兮完成签到 ,获得积分10
12秒前
勤劳的康乃馨完成签到 ,获得积分10
12秒前
我爱行楷完成签到,获得积分10
13秒前
SciGPT的应助被黑桃Q采纳,获得10
13秒前
宫城良官完成签到 ,获得积分10
13秒前
结实的翠芙完成签到,获得积分10
15秒前
易只羊完成签到,获得积分10
15秒前
泉汀野和完成签到,获得积分10
16秒前
Abandon1完成签到 ,获得积分10
17秒前
重要盼易完成签到,获得积分10
20秒前
闪闪松鼠完成签到 ,获得积分10
20秒前
21秒前
winwin完成签到 ,获得积分10
22秒前
22秒前
22秒前
愉快续完成签到 ,获得积分10
22秒前
无奈的迎丝完成签到 ,获得积分10
23秒前
微笑大象完成签到,获得积分10
23秒前
MySun完成签到 ,获得积分10
25秒前
lx完成签到,获得积分10
25秒前
零听发布了新的文献求助20
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179439
求助须知:如何正确求助?哪些是违规求助? 9569878
关于积分的说明 21807236
捐赠科研通 7774891
什么是DOI,文献DOI怎么找? 3433032
关于科研通互助平台的介绍 2556999
邀请新用户注册赠送积分活动 2478741